Table 1 Baseline profile, entire study population
Variable | Cases | Controls |
|---|---|---|
n | 59 | 210 |
Median age, years (IQR) | 63 (48–71) | 67 (55–73) |
Gender, n (%) | ||
 Male | 42 (71) | 106 (50) |
 Female | 17 (29) | 104 (50) |
Median BMI (IQR) | 28 (25–32) | 28 (25–33) |
Smoker, n (%) | 20 (34) | 42 (20) |
Diabetes mellitus, n (%) | 10 (17) | 49 (23) |
ASA status, n (%) | ||
 1 | 7 (12) | 18 (9) |
 2 | 28 (47) | 98 (47) |
  ≥ 3 | 24 (41) | 94 (45) |
Type of implant | ||
 Total joint arthroplasty | 28 (47) | 157 (75) |
 Fracture fixation device | 31 (53) | 53 (25) |
Infection site | ||
 Lower extremity | 56 (95) | 200 (95) |
 Upper extremity | 3 (5) | 10 (5) |
MRSA present, n (%) | 3 (5) | 6 (3) |
Preferred antibiotics, n (%) | ||
 Cefuroxime | 19 (32) | 106 (50) |
 Moxifloxacin | 13 (22) | 66 (31) |
 Clindamycin | 7 (12) | 38 (18) |